NFKB1 and atherosclerosis: Hence, we speculated that cilostazol inhibits the signaling of NF-kB and decreases transcription of different proteins, including ICAM-1, VCAM-1, E-selectin, TNF-α, interleukin-6 (IL-6), AGE, and ligands for RAGE in human atherosclerosis.